Solventum Corporation ( SOLV) - Stock Earnings
SOLV Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
SOLV Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 63.0 million USD | 2.0 billion USD |
| 2026Q1 | 13.0 million USD | 2.0 billion USD |
| 2026Q2 | 92.0 million USD | 2.2 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
SOLV Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.3 billion USD | 8.2 billion USD |
| 2024 | 479.0 million USD | 8.3 billion USD |
| 2025 | 1.6 billion USD | 8.3 billion USD |
| 2026 Est. | — | — |
SOLV
Price: $88.28
Earnings Per Share: 8.18 USD
P/E Ratio: 10.74
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United Kingdom
Market Capitalization: 15.0 billion